期刊论文详细信息
Clinical Proteomics
A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer
Hao Chen1  Yihong Sun1  Junjie Zhao1  Xuefei Wang1  Yupeng Yang1  Jing Han2  Shifang Ren2  Wenjun Qin2  Jianxin Gu2  Ruihuan Qin3 
[1] Department of General Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, 200032, Shanghai, China;Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, 138 Yixueyuan Road, 200032, Shanghai, China;Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, 138 Yixueyuan Road, 200032, Shanghai, China;Chinese Institute for Brain Research, 102206, Beijing, China;
关键词: Gastric cancer;    Peritoneal metastasis;    Glycomic analysis;    MALDI-TOF–MS;    Nomogram;   
DOI  :  10.1186/s12014-020-09297-4
来源: Springer
PDF
【 摘 要 】

BackgroundPeritoneal metastasis (PM) in gastric cancer (GC) remains an untreatable disease, and is difficult to diagnose preoperatively. Here, we aim to establish a novel prediction model.MethodsThe clinicopathologic characteristics of a cohort that included 86 non-metastatic GC patients and 43 PMGC patients from Zhongshan Hospital were retrospectively analysed to identify PM associated variables. Additionally, mass spectrometry and glycomic analysis were applied in the same cohort to find glycomic biomarkers in serum for the diagnosis of PM. A nomogram was established based on the associations between potential risk variables and PM.ResultsOverexpression of 4 N-glycans (H6N5L1E1: m/z 2620.93; H5N5F1E2: m/z 2650.98; H6N5E2, m/z 2666.96; H6N5L1E2, m/z 2940.08); weight loss ≥ 5 kg; tumour size ≥ 3 cm; signet ring cell or mucinous adenocarcinoma histology type; poor differentiation; diffuse or mixed Lauren classification; increased CA19-9, CA125, and CA724 levels; decreased lymphocyte count, haemoglobin, albumin, and pre-albumin levels were identified to be associated with PM. A nomogram that integrated with five independent risk factors (weight loss ≥ 5 kg, CA19-9 ≥ 37 U/mL, CA125 ≥ 35 U/mL, lymphocyte count < 2.0 * 10 ~ 9/L, and H5N5F1E2 expression ≥ 0.0017) achieved a good performance for diagnosis (AUC: 0.892, 95% CI 0.829–0.954). When 160 was set as the cut-off threshold value, the proposed nomogram represented a perfectly discriminating power for both sensitivity (0.97) and specificity (0.88).ConclusionsThe nomogram achieved an individualized assessment of the risk of PM in GC patients; thus, the nomogram could be used to assist clinical decision-making before surgery.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202104247776883ZK.pdf 2841KB PDF download
  文献评价指标  
  下载次数:22次 浏览次数:1次